unknown
Stage
About
VirXcel develops innovative antiviral treatments using macrocyclic peptides that target conserved viral protein sites, focusing initially on intranasal therapeutics to prevent and mitigate respiratory infections like COVID-19.
Explore VirXcel's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.